As the neuromuscular field continues to evolve, so do the challenges we face – whether it’s ensuring equitable access to therapies, navigating regulatory uncertainty, or aligning with the expectations of payors and health technology assessment (HTA) bodies.
The 8th International TREAT-NMD Conference in Lisbon this February will bring together the full spectrum of stakeholders to explore these issues head-on. It’s a space for open discussion and practical, solution-focused thinking.
If you’re planning to attend, don’t forget that early bird rates are available until 31st July 2025.
Register here: TREAT-NMD Conference Registration
